Entero Healthcare Solutions Limited — PPTs, 08-08-2025: Investor Presentation

Here's a summary tailored to your preferences:

**1. Financial Highlights:**

Q1 FY26 revenue jumped 28% YoY to ₹1,403.8 Cr, outpacing industry growth. Profit After Tax surged 47% to ₹30.2 Cr. Gross margins expanded to 9.9% and EBITDA margins to 3.6%. Net Operating Working Capital remained stable at 66 days.

**2. Strategic Initiatives & Growth Drivers:**

Strategy focuses on consolidating the fragmented healthcare supply chain via organic growth and disciplined M&A. Expanding into new categories and driving efficiencies aims for profitable growth and improved return ratios.

**3. Business Developments:**

Entero's 28% Q1 FY26 revenue growth (vs. 9% IPM) indicates strong performance. Expanded operational reach with 71,000+ retail customers and 102 warehouses. Awarded "Excellence in Healthcare Supply Chain and Logistics- 2024."

**4. Market Position & Competitive Advantage:**

As a top-three Indian healthcare product distributor, Entero leverages its pan-India presence and proprietary technology. Over 50 acquisitions enable rapid scale-up, providing a strong competitive edge in a consolidating market.

**5. Investor Implications:**

Strong Q1 results with outperformance and margin expansion signal positive growth potential. Entero's disciplined M&A and operational efficiency in a large, consolidating market suggest a compelling investment.